Cauliflower Mosaic Virus TAV, a Plant Virus Protein That Functions like Ribonuclease H1 and is Cytotoxic to Glioma Cells by Turri, Valentina et al.
Research Article
Cauliflower Mosaic Virus TAV, a Plant Virus Protein That
Functions like Ribonuclease H1 and is Cytotoxic to Glioma Cells
Valentina Turri ,1 Olga S. Latinovic,2,3 Massimiliano Bonafe`,4 Ngeh Toyang,2,5
Maria Parigi,6,7 Matteo Calassanzio,8 Pier Luigi Martelli,9 Alessandro Vagheggini ,10
Giulia Abbati,11 Anna Sarnelli,12 Rita Casadio,9 Claudio Ratti,8 Paola Massi,6
James E. Schoelz,13 Maria S. Salvato,2 Filippo Piccinini,14 and Giovanni Martinelli14
1Healthcare Direction, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, FC, Italy
2Institute of Human Virology (IHV), University of Maryland, School of Medicine, 21201 Baltimore, MD, USA
3Department of Microbiology and Immunology, University of Maryland, School of Medicine, 21201 Baltimore, MD, USA
4Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, 40126 Bologna, Italy
5Educational and Scientific (LLC), 21201 Baltimore, MD, USA
6Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna (IZSLER), 47122 Forl`ı, Italy
7Istituto Oncologico Romagnolo (IOR), 47122 Forl`ı, Italy
8Department of Agricultural and Food Sciences, School of Agriculture and Veterinary Medicine, University of Bologna,
40127 Bologna, Italy
9Department of Pharmacy and Biotechnology, Interdepartmental Centre “L. Galvani” for Integrated Studies of Bioinformatics,
Biophysics and Biocomplexity, Biocomputing Group, University of Bologna, 40126 Bologna, Italy
10Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS,
47014 Meldola, FC, Italy
11Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola,
FC, Italy
12Medical Physics Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014Meldola, FC, Italy
13Division of Plant Sciences, University of Missouri, 65211 Columbia, MO, USA
14Scientific Directorate, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014Meldola, FC, Italy
Correspondence should be addressed to Valentina Turri; valturri@gmail.com
Received 29 August 2019; Revised 22 December 2019; Accepted 30 January 2020; Published 16 March 2020
Guest Editor: Chen-Huan Yu
Copyright © 2020 Valentina Turri et al. *is is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Recent comparisons between plant and animal viruses reveal many common principles that underlie how all viruses express their
genetic material, amplify their genomes, and link virion assembly with replication. Cauliflower mosaic virus (CaMV) is not
infectious for human beings. Here, we show that CaMV transactivator/viroplasmin protein (TAV) shares sequence similarity with
and behaves like the human ribonuclease H1 (RNase H1) in reducing DNA/RNA hybrids detected with S9.6 antibody in
HEK293T cells. We showed that TAV is clearly expressed in the cytosol and in the nuclei of transiently transfected human cells,
similar to its distribution in plants. TAV also showed remarkable cytotoxic effects in U251 human glioma cells in vitro. *ese
characteristics pave the way for future analysis on the use of the plant virus protein TAV, as an alternative to human RNAse H1
during gene therapy in human cells.
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1. Introduction
Cancer remains a major public health problem worldwide.
Current standards of cancer therapy include resection
surgery (if applicable), radiation, chemotherapy, immuno-
therapy, and/or biological therapy [1]. *e development of
new therapies, such as targeted gene therapies, may provide
an effective and nontoxic method of treating cancer.
A connection between the regression of cancer and
viruses has long been theorized and reports of regression
(cervical cancer, Burkitt’s lymphoma, and Hodgkin’s dis-
ease) after vaccination or infection with a related virus
appeared in the early 20th century. Efforts to treat cancer
through vaccination or infection with a virus deliberately
started in the mid-20th century.
Plant viruses and vertebrate viruses are believed to exist
in two different and nonoverlapping biological niches [2]. To
date, plant viruses have not been described as pathogens for
vertebrates or humans or known even to infect them [3].
Striking similarities have been observed between a plant
pararetrovirus, Cauliflower mosaic virus (CaMV), and an-
imal retroviruses, specifically their replication through
productive reverse transcription and their high recombi-
nation rate [4]. However, there are also remarkable differ-
ences that include the tropism for two different kingdoms,
the nature of the CaMV genome (a molecule of circular
double-stranded DNA) and its lack of integration into host
cell chromosomes [5]. Precisely, for its replication, CaMV is
not dependent on the host DNA replication apparatus, in
contrast to the geminiviruses (ssDNA plant viruses) that
must overcome the lack of DNA replication factors in G0
cells, similar to the animal DNA tumor viruses such as SV40
and adenovirus [6]. *ere are just a few examples of plant
viruses or plant virus proteins known to interact with human
cells. Tobacco mosaic virus has been shown to induce en-
doplasmic reticulum stress-related autophagy in HeLa cells
[7]. Tomato bushy stunt virus P19 has been shown to
suppress RNA silencing in animal cells downstream of
miRNA maturation [8, 9]. Although the CaMV 35S plant
promoter is reported to be active in human enterocyte like
cells [10], the expression of CaMV proteins in human cells
has not been investigated.
Cauliflower mosaic virus (CaMV) is a DNA plant virus
and is the type member of the family Caulimoviridae, which,
together with the hepadnaviruses, belong to the group of
pararetrovirus, which have a DNA genome but replicate by
reverse transcription. *e CaMV genome is a circular
double-stranded DNA of approximately 8,000 bp and is
encapsidated within a 50 nm icosahedral particle. CaMV
infects principally plants of the Brassicaceae and Solanaceae
families (turnips, cauliflowers, sprouts, and cabbages). Plant
viruses replicate within an infected cell, move from cell to
cell, and are transported from plant to plant. Once intro-
duced within a host cell, virions migrate to the nuclear
envelope, where they decapsidate. *e viral genomes then
enter the nucleus where all the gaps present in the genome
are sealed and the covalently closed DNA then associates
with host histones to form a supercoiled minichromosome
that does not integrate into the host chromosomes and that
is transcribed by the host RNA polymerase II to generate two
mRNAs, the polycistronic 35S RNA comprising the entire
genome encoding six proteins, and the 19S RNA encoding a
single protein, the transactivator/viroplasmin protein
(TAV), and the two mRNAs then move to the cytoplasm. In
the cytoplasm, TAV is translated from the 19S RNA and
aggregates in small inclusion bodies, where it transactivates
translation of all other viral proteins from the 35S RNA [11].
TAV is recognized as a multifunctional effector interacting
with a broad array of host proteins and either initiates the
innate immunity reaction in a nonpermissive host or in-
terferes with it in a permissive host [12–14]. TAV is com-
posed of 520 amino acids that form an alpha-helical motif
and is the least conserved protein within the CaMV genome.
It contains a nuclear export signal (NES) at the N-terminus,
a TAV domain, two nuclear localization signals (NLS), two
RNA binding domains, and a putative zinc finger at the
C-terminus [15]. In CaMV-infected plants, TAV is a
nucleocytoplasmic shuttling protein [16] and nuclear import
of TAV by the bipartite NLS and the nonconventional NLSa
is likely through the importin alpha pathway. A minor part
of TAV import could also occur through interactions be-
tween the TAV domain and L13 and L18 and other ribo-
somal proteins. *is process causes TAV retention within
the nucleolar, as opposed to the nucleoplasmic compartment
[17]. TAV is a translational reinitiation factor that associates
with the host translational machinery. *is function is
mediated by physical interactions between the TAV domain,
the initiation factor eIF3 8 (subunit g), L13, L18, and L24
(ribosomal proteins) [16]. *e hallmark of the RNase H/
caulimovirus nucleic acid binding motif is a stretch of 40
amino acids with 11 highly conserved residues, seven of
which are aromatic. Point mutations, insertions, and dele-
tions indicated that the integrity of the motif is important for
binding. *e similarity between the RNase H and the
caulimovirus domain suggests a common interaction with
duplex RNAs of these two different groups of proteins [18].
However, little is known about TAV effects in the non-
permissive human host, and the aim of this study is to
determine if plant virus proteins may have the same activity
in mammalian and plant cells.
2. Materials and Methods
2.1. Computational Methods: Protein-DNA and Protein-
Protein Interactions. Interactions between DNA and pro-
teins from CaMV were predicted with DP-bind [19], a freely
available program that combines three different tools
(support vector machines, kernel logistic regression, and
penalized logistic regression) to address the two-class
classification problem consisting in recognizing DNA-
binding and nonbinding residues.
Prediction considers the input sequence and the Position
Specific Scoring Matrix (PSSM) compiled upon PSI-BLAST
search for similar sequences. Consensus between two out of
the three methods (majority consensus) has been adopted as
a prediction criterion. *e performance reported for the
majority consensus method is 76% accuracy, 76% sensitivity,
and 75% specificity [19]. Possible interactions between viral
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and human proteins have been inferred by screening the
human proteome for sequences sharing similarity with
known plant interactors and by analyzing the retrieved
proteins in the context of the STRING human interactome
[20]. Sequence similarity was searched with BLAST.
2.2. Computational Methods: Modelling of CaMV TAV
Protein. *e TAV three-dimensional structure is unknown
and no template is available for the full-length modelling of
the protein. To search for possible structural templates, the
CaMV TAV sequence has been launched against Pfam [21],
a database containing hidden Markov models for 17929
different protein domains. A 48-residue long domain sig-
nificantly aligns with Pfam PF01693 (Cauli VI), which in-
cludes domains endowed with a three-dimensional structure
in the protein database (PDB). Among them, the most
similar to TAV’s domain (target) is the hybrid domain of the
human RNase H1, a specialized enzyme that can specifically
resolve long DNA-RNA hybrids that can be used as a
template [22]. In particular, we adopted the PDB file 3BSU
[23], reporting the structure of the human domain in in-
teraction with double-stranded RNA. *e domain has been
modelled with Phyre2 [24] on the basis of the hybrid domain
of human RNase H1 (PDB code: 3BSU). *e secondary
structure for P6 protein has been predicted with PSIPRED
[25].
2.3. Cell Culture and Transient Transfection. HEK293T cells
(human embryonic kidney cell line 293 T cells that contain
the SV40 T-antigen) were a gift of the European Brain
Research Institute (EBRI) Rita Levi-Montalcini in Rome.
HEK293T cells were grown in Dulbecco’s modified Eagle’s
Medium High Glucose (DMEM High, Euroclone) supple-
mented with 10% fetal bovine serum (Euroclone) and 1%
Penicillin/Streptomycin (Life Technologies) and they were
cultured at 37°C and 5% CO2. A human glioblastoma cell
line (U251, National Cancer Institute) was maintained in
Eagle’s Minimum Essential Medium (ATCC, 30-2003)
supplemented with 10% Fetal Bovine Serum (FBS, Gibco,
*ermo Fisher Scientific) at 37°C in a humidified 5% CO2
atmosphere. CaMV strain CM1841 full-length ORF I, III, IV,
V, and VI (corresponding to MP, VAP, CP, EP, and TAV,
respectively) were cloned from vector pS10-08 (CaMV strain
CM1841 cloned into pBR322) into a mammalian expression
vector pcDNA 3.1 (+) (EV), according to the native virus
gene sequence (see database Genbank: V00140.1). *e full-
length ORF VI gene differs from the native sequence by a
point mutation A402C (see database Genbank: V00140.1).
pcDNA 3.1_P2A EGFP (EGFP) was used to test transient-
transfection efficiency. HEK293T cells were seeded on
coverslips within the wells of a 6-well plate at a density of
2×105 cells/well (for confocal experiments) or in a T75 flask
at a density of 3×106 cells/flask (for western blot); cells were
transiently transfected with 0.5 μg of DNA/well and 8 μg of
DNA/flask of each DNA plasmid pcDNA3.1 (EV),
pcDNA 3.1 ORF IV (CP), and pcDNA 3.1 ORF VI (TAV)
(Genscript) with Polyethylenimine (PEI) 1 : 6 ratio with
DNA. Experimental conditions include HEK293T cells
transiently transfected with pcDNA 3.1 ORF IV (CP) and
pcDNA 3.1 ORF VI (TAV), while controls include
HEK293T cells not transfected and transiently transfected
with EV and EGFP.
Transfection efficiency was found to be around 90% at 48
hours after transfection. U251 cells were seeded into a 24-
well plate at a density of 2×104 cells/well; cells were tran-
siently transfected with 0.5 μg of DNA/well of each DNA
plasmid with 50 μl of U251 Cell Avalanche transfection
reagent mix (EZ Biosystems) 1 : 5 ratio with DNA. Exper-
imental conditions include U251 cells transiently transfected
with pcDNA 3.1 (+) ORF I (MP), pcDNA 3.1 ORF III (VAP),
pcDNA 3.1 ORF IV (CP), pcDNA 3.1 ORF V (EP), pcDNA
3.1 ORF VI (TAV), and pcDNA 3.1 ORF VI in which the
pathogenicity/host-range/avirulence domain of TAV12
(amino acids 2-113) was deleted (TAV deleted); negative
controls include U251 cells not transfected, treated with
transfection reagent only (media), and transiently trans-
fected with EV and EGFP. Transfection efficiency was tested
around 30–50% at 48 hours after transfection.
2.4. Cellular Fractionation. Cell’s nucleus and cytoplasm
separation was performed as previously described [26], with
minor modifications. Nontransfected HEK293T cells and
transiently transfected HEK293T cells (EV and TAV), 48 h
after transfection, were twice washed in PBS 1X, resus-
pended in TM5 buffer (10mM Tris, 5mM MgCl2), and
incubated 1 minute at room temperature and 5 minutes on
ice during rotation. Triton X-100 (10% in H2O) was added
and the suspension was passed through a syringe with a 22G
needle and centrifuged for 10 minutes at 4°C. *e super-
natant (cytoplasm proteins) was collected and supplemented
with Halt Protease and Phosphatase Inhibitor; then proteins
were quantified using the Coomassie (Bradford) Protein
Assay Kit (*ermo Fisher Scientific) and prepared for
western blotting. Western blotting of cytosolic proteins was
performed using histone H3 (Merck Millipore) for an en-
dogenous nuclear marker, rabbit anti-TAV, and GAPDH-
HRP-conjugated antibody (Origene, 2D9) as a control to
show the absence of cytoplasm contamination. *e pellet
was resuspended in TM5 buffer, centrifuged twice for 10
minutes at 4°C, and the supernatant was aspirated to dry the
nuclear pellet. Nuclear proteins were extracted using RIPA
Buffer (150mM NaCl, 1% Triton X-100, 0.5% sodium
deoxycholate, 0.1% SDS, 50mM Tris pH 8.0) supplemented
with Halt Protease and Phosphatase Inhibitor and DNase
1 μg/ml (Qiagen), incubated 30 minutes on ice in agitation,
and then spun at 17000g for 15 minutes at 4°C. Nuclear
proteins (supernatant) were collected and prepared for
western blotting that was performed using the GAPDH-
HRP-conjugated antibody (Origene, 2D9) for endogenous
cytoplasm marker, anti-TAV rabbit polyclonal serum
[27, 28], and histone H3 as a control for nuclear
contamination.
2.5. Western Blot. HEK293T cells were transiently trans-
fected with EV, CP, and TAV; nontransfected cells were used
as a negative control. After 48 h, cells were lysed in RIPA
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Buffer with Halt Protease and Phosphatase Inhibitor, in-
cubated 15 minutes on ice, and then spun at 17,000g for 15
minutes at 4°C. *e amount of total protein was quantified
using the Coomassie (Bradford) Protein Assay Kit (*ermo
Fisher Scientific). *e supernatants of each sample were
collected and mixed with Bolt LDS Sample Buffer and Bolt
Sample Reducing Agent (*ermo Fisher Scientific).
Samples were boiled for 5 minutes, loaded on a Bolt
4–12% Bis-Tris Gel (*ermo Fisher Scientific), and trans-
ferred to a PVDF nitrocellulose membrane (Biorad). *e
blots were blocked in 0.1% Tween-20 and 5% nonfat milk
(Biorad) in Tris Buffered saline (Biorad) for 1 h at room
temperature, and then membranes were tested for different
antibodies: anti-TAV rabbit polyclonal serum (1 : 250)
[19, 20] and anti-CP rabbit polyclonal serum (1 : 250, DSMZ
AS-0206) overnight at 4°C, followed by the rabbit IgG-heavy
and light chain antibody HRP-conjugated (Bethyl). Detection
was performed using ClarityWestern ECL substrate (Biorad),
according to the manufacturer’s instructions, and images
were acquired using a Chemidoc XRS System (Biorad).
2.6. Plant Material and Infection. B. rapa plants (var.
“Nagaoka”) were grown in a greenhouse at 20± 2°C with a
16 h photoperiod. After 15 days of growth, the plants were
infected with an infectious CaMV clone, CaMV strain
CM1841 excised from the pS10-08 vector (full-length CaMV
strain CM1841 cloned into pBR322) by digestion with SalI.
Mechanical inoculation was performed using Paul buffer
(phosphate buffer 0.05M pH 7.0, 5mM DIECA, 1mM
EDTA, and 5mM sodium thioglycolate) and celite as an
abrasive powder. *e typical symptoms of curling and leaf
mosaic appeared two weeks after inoculation. *irty-five
days after infection, samples from infected plants were
collected for analyses at the ultrastructural level. Nonin-
fected B. rapa plants, inoculated with Paul buffer alone, were
used as negative controls.
2.7. Tissue Processing for Transmission Electron Microscopy
(TEM). Several portions of the infected and uninfected leaf
tissue were sampled using an ultrathin blade in the presence
of 5% glutaraldehyde in 0.1M potassium phosphate buffer
(pH 7.2). In the same buffer, the HEK293T EV and TAV
cells, at 48 h after transfection, were resuspended after
centrifugation at 1000g for 5 minutes. Glutaraldehyde fix-
ation was improved at the pressure of 2 bar for 20min before
embedding with an Araldite/TAAB812 Resin kit and
mounting on the grids as previously described [29].
2.8. Immunocytochemical Labelling. Sample sections were
processed as previously described [29] on grids for electron
microscopy, adding 7% uranyl acetate to the contrasting
step. After drying with the filter paper, the grids were ex-
amined with a 100 kV PHILIPS CM10 electron microscope.
2.9.HEK293TCells Staining forConfocalMicroscopyAnalysis.
HEK293Tcells were grown on coverslips (0.17mm thickness
round cover glass 18mm, Warner Instruments) in 6-well
plate, and 0.5 μg of DNA (pcDNA3.1, pcDNA 3.1 ORF IV
(CP), and pcDNA 3.1 ORF VI (TAV)) with PEI 1 : 6 ratio
with DNA was used for each well. Cells were fixed 48 hours
after transient transfection in 4% paraformaldehyde (PFA)
(Image-IT,*ermo Fisher Scientific) for 15 minutes at room
temperature (RT). Afterwards, samples were permeabilized
and blocked with 0.3% Triton X-100 and 5% FBS in PBS for 1
hour at RT. Coverslips were incubated with primary anti-
bodies for CP and TAV (1 : 500 in blocking solution)
overnight at 4°C, followed by the appropriate secondary
antibody goat anti-rabbit Alexa Fluor 594 (Life Technolo-
gies, 1 : 600 in blocking solution) for 1 h at RT.
Fluorescence images were acquired on a Carl Zeiss
Axioskop 40 Microscope. *e following commercially
available antibodies were used in immunofluorescence:
polyclonal rabbit anti-CaMV IgG (DSMZ, AS-0206) and
goat anti-rabbit IgG (H+ L) cross-adsorbed secondary an-
tibody conjugated to Alexa Fluor 594 (red color; 1 : 600 in
blocking solution). TAV antiserum is a noncommercial
rabbit anti-TAV polyclonal serum [27, 28].
2.10. Confocal Image Acquisition and Analysis. Confocal
images of cell-associated fluorescence were acquired using
the Zeiss LSM 800 confocal system (Carl Zeiss Microscopy,
Germany). *ree laser lines, 405 nm (blue, for nuclei),
488 nm (green, S9.6), and 561 nm (red, TAV), were used in
these imaging experiments. Blue, green, and red signals were
separated by a quad DAPI/FITC/TRITC/Cy5 dichroic beam
splitter and were further acquired using a Gasp detector
(Carl Zeiss LSM 800, Germany). A Plan-Apochromat 63x/
1.4 Oil DIC objective (Carl Zeiss LSM 800, Germany) was
used to visualize multicolored, labelled cell samples. All the
parameters used in confocal microscopy were consistent in
each experiment, including the laser excitation power, de-
tector, and offset gain. Software Zen Blue (Carl Zeiss Mi-
croscopy) was used to generate original images and to collect
z-stacks in order to achieve better three-dimensional in-
formation about the spatial location of TAV as subcellular
localization within the cells (1 μm thickness of sample slices).
Negative control samples (nontransfected and EV) were
stained with the same conditions as described above. All the
images were acquired under the same instrumental settings.
To assure the quality of acquired images, we took mea-
surements with the same size of optical sections in three
channels (405/488/561 nm). Furthermore, signal/noise ratio
was assured by averaging data for every single image ac-
quired. *e saturated signal was avoided by using the range.
Software Zen Blue was used to measure cell-associated in-
tensity of the green events in nontransfected cells, EV, CP,
and TAV samples. Each sample was examined by analyzing a
large area [30] or at least 10 different imaging fields. Total
intensity of the sample was measured and averaged among
all images per set, in order to assure the statistics.
2.11. Cytotoxicity Assay. Cytotoxicity assays using trypan
blue were performed on U251 cells not transfected, treated
with media only, and transiently transfected with EV, MP,
VAP, CP, EP, TAV, and TAV-deleted vectors. *e results
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come from five biological replicates (technical duplicate of
the data for each biological experiment). Cell viability data
was acquired 5 days after transient transfection (as described
above) using the Trypan Blue Assay reagent with the aid of
the Countess II automated cell counter (*ermo Fisher
Scientific). Cells were cultured as described above with a
change of media after 72 h. *e sample sizes of the vitality
data differ as not every experimental condition has been
analyzed in each experiment. Results are summarized as
robust descriptive indices (median and interquartile range)
that are not influenced by extreme values.
2.12. Statistical Analyses. *e null hypotheses of equality
between medians versus the alternative hypothesis of in-
equality have been inferred by means of the nonparametric
Mann–Whitney rank sum test; α� 0.05 significance level has
been set.
3. Results
3.1. TAV Sequence Similarity with the Human RNase H1.
We screened the human proteome for sequences sharing
significant similarity with CaMV viral proteins, in order to
elucidate the possible effects of viral proteins within human
cells. Among CaMV proteins analyzed, TAV is the only one
sharing significant similarity with a human protein (see
Table S1 in the Supplementary Material for comprehensive
analysis). TAV (UniprotKB: P03558) is a transactivator/
viroplasmin protein (P6) involved in the translation of
polycistronic viral DNA and its domains have been previ-
ously described [14, 31, 32]. Figure 1(a) shows the sequence
alignment between target (TAV) and the hybrid domain of
the human RNase H that we used as template (Protein Data
Bank code: 3BSU) and the comparison between their sec-
ondary structures as predicted with PSIPRED (for both
target and template) or derived from the structure (for the
template). Out of 48 residues, 15 are conserved (31.3% se-
quence identity) [18]. From the structural alignment be-
tween template and model (that superimpose with a Root
Mean Square Deviation of 0.15 nm), it is possible to infer
possible RNA interaction sites for TAV. Figure 1(b) shows
the residues in the model with a distance lower than 0.5 nm
from the RNA molecule transferred from the template. *e
hypothesis that the TAV domain can interact with human
nucleic acids is corroborated by the fact that 15.2% of TAV
residues are predicted to be protein-DNA interaction sites
using the programDP-bind (Figure 1(a)). See Table S2 in the
Supplementary Material for comprehensive analysis. We
further characterized the role of TAV by searching for
possible physical interactions of CaMV viral proteins with
human proteins. *e possible interactors of TAV in the
natural host cells, in plants, have been previously reported
[14, 33–37]. A clear similarity with human proteins is shown
for some of the plant interactors, suggesting that human
analogous can conserve the interaction with TAV. See Table S3
in the Supplementary Material for comprehensive analysis.
3.2. Nuclear Expression of TAV in Transiently Transfected
HEK293T Cells. In plants, TAV is actively transported into
the nucleus through its two importin-α-dependent nuclear
localization signals [17]. Since TAV is known to be a
nucleocytoplasmic shuttle protein [16], we examined the
nuclear expression of TAV in transiently transfected
HEK293T cells (TAV-HEK293T cells), which are charac-
terized by a high transfection efficiency and a high level of
DNA/RNA hybrids, by using a nuclear separation protocol.
Using western blot, we found that TAV is expressed ex-
clusively in TAV-HEK293T cells, both in the cytoplasm and
in the nucleus (Figures 2(a) and 2(b)). See Figures S1–S3 in
the Supplementary Material for comprehensive image
analysis (the quality of the nuclear separation protocol is
shown).
(a)
PRO 166
GLY 167
GLY 164
VAL 168
TYR 170
LYS 159
TRP 155
LYS 172
LYS 171
ALA 168
ILE 138
(b)
Figure 1: Modelling the 138-184 domain of CaMV TAV protein. (a) TAV sequence is shown, highlighting (in bold) residues putatively
interacting with nucleic acids as predicted with DP-bind. Fragment 138-184 is aligned with the hybrid-binding domain of human RNase H1,
whose structure is resolved (PDB: 3BSU) and has been adopted as a template. *e alignment of structure-derived and computed secondary
structures are also reported. (b)*e structure of the double-stranded RNAmolecule cocrystallized with the human protein is transferred on
the modelled domain upon target-template superimposition. Balls and sticks representation is adopted for the RNA molecule. Residues
represented with red VanDerWaals spheres are less than 0.5 nm distant from the RNAmolecule. Residuemarked ILE 138 is the N-terminus
of the modelled domain.
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In order to confirm the nuclear expression of TAV, we
analyzed EV and TAV- HEK293T cells using transmission
electron microscopy (TEM). Only rare gold particles are
seen randomly scattered over sections from healthy plants or
EV- HEK293T cells indicating the absence of any endoge-
nous substrates for the antibodies used (Figures 2(c) and
2(f)). Specific nuclear localization of gold particles was
observed using the TAV antibody for TAV-HEK293T cells
or CaMV-infected plant tissue labelling, respectively. TAV
was localized intranuclearly both in TAV- HEK293T cells
(Figures 2(d) and 2(e)) and in CaMV CM1841-infected
turnip leaf cells which showed the typical symptoms of
curling and leaf mosaic, used as a positive control
(Figures 2(g) and 2(h)). Interestingly, nucleolar gold la-
belling on TAV-HEK293Tsamples (Figure 2(d)) and specific
labelling of infected chloroplasts (Figure 2(h)) were observed
using the antibody against TAV.
3.3. DNA/RNA Hybrids Reduction in TAV-HEK293T Cells.
Since TAV protein shows a homology with the mammalian
RNase H1, we tested for its effect in reducing DNA/RNA
hybrids in TAV-HEK293T cells, using an anti-R-loop an-
tibody, S9.6 Ab [38]. As shown in the boxplots (Figure 3(a)),
EVw EVn TAVw TAVn
75
50
EVw EVn TAVw TAVc
75
50
EV
H
ek
Not infected
Tu
rn
ip
CaMV
TAV TAV
CaMV
(a)
(c) (d) (e)
(f) (g) (h)
(b)
Figure 2: TAV detection with western blot (WB), transmission electron microscopy (TEM), and confocal microscopy. (a) Western blot
shows total proteins (w) and nuclear proteins (n) of EV and TAV samples, immunoblotted with anti-TAV polyclonal serum. Arrow
indicates TAV band (62 kDa), present in TAV sample only, in both W and N. Since the TAV antibody is a rabbit polyclonal antisera, it
showed also a nonspecific band, also in EV sample just above the TAV band. Full-length blots/gels are presented in Supplementary Figure 1.
(b)Western blot shows total proteins (w) and cytosolic proteins (c) of each sample, immunoblotted with anti-TAV polyclonal serum. Arrow
indicates the TAV band, present in the TAV sample only. Full-length blots/gels are presented in Supplementary Figure 2. (c–h) Immunogold
electron microscopy showing localization of CaMV TAV in Hek293T (c, d, e) and turnip cells (f, g, h). Ultrathin sections were im-
munostained with anti-TAV and gold-labelled secondary antibody. EV (c) and noninfected turnip cells (f ) were used as a negative reference.
Gold particles are indicated by arrows at low magnification (d, g) and clearly visible at higher magnification (e, h). *e bars represent
200 nm. *e letter symbols stand for the following: N: nucleus; Nu: nucleolus; NM: nuclear membrane; M: mitochondria; L: lysosome; RE:
endoplasmic reticulum; CW: cell wall; CH: chloroplast; V: vacuole; S: starch.
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the S9.6 Ab fluorescence signal registered in TAV-
HEK293T cells had a median value of 1,076 arbitrary units
(AU, i.e., grey levels at 16-bit resolution) which is lower
when compared to 2,692, 1,938, and 1,603 AU for non-
transfected cells, EV, and CP-HEK293T cells, respectively.
Empirical evidence leads one to firmly reject the null hy-
pothesis when comparing TAV-HEK293Tcells with EV-
HEK293T cells (P value <0.001); indeed, both graphical and
descriptive comparisons point out substantial differences.
On the contrary, the difference between the central tendency
of CP and EV-HEK293Tcells was not statistically significant
(P value� 0.061). Taken together, our results suggest that
TAV acts like RNase H1 protein in human cells, while the
median lower level of CP is probably to be ascribed to its
close association with other nucleic acid binding proteins or
to the nucleic acid binding of CP through its own predicted
motifs (e.g., the zinc finger motif, CXCX7HX14H, described
in the PROSITE entry PDOC50158 [39]). See Figure S4 in
the Supplementary Material for comprehensive analysis.
3.4. TAV’s Cytotoxicity to Human Glioma Cells (U251 Cells).
We then sought to investigate whether TAV interferes with
cell viability. To this aim, cytotoxicity assays using trypan
blue were performed on U251 human glioma cells, which
have been transiently transfected with the CaMV proteins
analyzed. As shown in the boxplots (Figure 3(b)), the vitality
data of TAV-U251 samples reveal the lowest median values.
*is is more noticeable for the negative controls (83.6% for
TAV compared to around 94.5%, 94.9%, and 92.6% for
nontransfected cells, media only, and EV, respectively) and
VAP and EP (96.0% and 93.5%median vitality, respectively).
TAV-deleted median vitality data is 91.4%, therefore com-
parable to negative controls. Movement protein (MP) and
CP median vitality values (89.7% and 86.6%, respectively)
are closer to the median TAV one. *e interquartile ranges
show that the vitality values of nontransfected and TAV-
deleted are highly concentrated around their median values,
whereas MP and TAV show higher dispersion. Empirical
evidence leads one to firmly reject the null hypothesis when
comparing TAV with nontransfected (P value <0.001) and
media-control values (P value� 0.004); indeed, both
graphical and descriptive comparisons point out substantial
differences.
4. Discussion
Our results reveal a new and unexpected role for CaMV
TAV in reducing DNA/RNA hybrids in HEK293T cells and
being cytotoxic for U251 cells. DNA/RNA hybrids are
formed continuously throughout the genome during RNA
transcription and DNA duplication [40]. Together with the
displaced single-strand DNA filament, DNA/RNA hybrids
are collectively called R-loops [40]. R-loops are a threat to
genome integrity due to their capability to promote DNA
double-strand breaks, chromosome rearrangements, and
replication fork stalling [40]. R-loops behave as hotspots of
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Figure 3: Quantification of TAV effects in human cells. (a) TAV-induced reduction of DNA/RNA hybrids in HEK293Tcells. Boxplots and
descriptive statistics of the fluorescence signal data in HEK293T cells. *e interquartile ranges show that the cell-associated fluorescence
signal values of EV and TAV are well concentrated around their median values, whereas nontransfected and CP values show higher
dispersion. A high-fluorescence outlier has been identified for the EV control. (b) TAV-induced cytotoxic effects in U251 cells. Boxplots and
descriptive statistics of the cytotoxicity data in U251 cells. Each box shows the first and third quartiles (bottom and top horizontal lines,
respectively: box height is the interquartile range, IQR) and the median value (thick horizontal line) and whiskers’ (vertical lines) ends are
the lowest/highest datum within 1.5× IQR from the box extremities; all values outside these intervals are considered as outliers (black dots).
Tables collect sample size, median, and the interquartile range (IQR, i.e., the difference between the third and first quartiles).
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genomic instability in a variety of organisms. Current
models suggest that uncontrolled R-loops are a hazard to
genome integrity, and the expression of RNA-DNA hybrid-
binding proteins in various cancer types is associated with
survival [41]. Accordingly, mechanisms that prevent R-loop
accumulation (e.g., THO/TREX and BRCA2 [39, 40]) en-
hance genome stability in human cells [39], whereas the
sequestration of hTREX by Kaposi’s sarcoma-associated
herpesvirus protein ORF 57 leads to R-loop formation and
genome instability [40]. Nevertheless, DNA/RNA hybrids
exert important physiologic roles in gene regulation, as they
control gene expression activation and termination [40].
Moreover, depletion of DNA/RNA hybrids by RNase H1
overexpression has been shown to impair telomere ho-
meostasis in cancer cells that maintain telomere length via
the telomerase-independent “alternative lengthening of
telomeres” (ALT) pathway [42]. Indeed, these tumor cells
need to maintain precise levels of DNA/RNA hybrids to
support telomeric homologous recombination (HR) without
compromising telomere integrity. Together with our find-
ings, these data suggest that particular sets of cancer cells,
such as those carrying active ALT pathway, may be pref-
erentially sensitive to DNA/RNA hybrid depletion and may
be suitable targets for TAV/RNase H1 overexpression-based
gene therapy.
5. Conclusions
*ese proof-of-concept data open the door to cross-king-
dom use of plant virus proteins in human therapies. Since
RNase H-mediated degradation of ASOs, which form an
RNA/DNA hybrid once bound to the RNA, is now under
clinical investigation for amyotrophic lateral sclerosis
among other neurological diseases [43], TAV—a plant virus
protein—may become a key player in future gene therapy
scenarios in a variety of human diseases, including cancer
and neurodegeneration.
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